CRL - שולי רווח נקי Charles River Laboratories International, Inc.

לוגו גרפי של Charles River Laboratories International, Inc. (CRL)

The net profit margin reflects the current trend, with the metric currently at 1.00. Charles River Laboratories (CRL) maintains a predictable cash flow due to its status as the primary outsourcer for the pharmaceutical market. The business relies on unique patents and preclinical models while operating within the strict regulatory framework of the FDA. However, reduced investment in biotech startups and pressure from eco-activists create certain risks for demand.

Charles River Laboratories (CRL) - שולי רווח נקי מ-04.07.2022 עד 19.11.2026

Charles River Corp (CRL) - פילוחי מדדים ודוחות פיננסיים

- שווי שוק ותחזית יעד של אנליסטים:
אנליטיקה מסכמת של החברה:Charles River Laboratories International, Inc. - CRL
מוצרים מוגמרים של Charles River Lab

This indicator determines the share of net profit in every dollar of revenue, reflecting the efficiency of operating expense management and the actual balance of market demand. By analyzing operating net profit margins, investors assess the business resilience of Charles River Laboratories (CRL), where high loyalty among biopharma clients guarantees stable income, although stringent USDA requirements for animal husbandry create constant pressure on profitability.